Thymosin Alpha-1
An immune-modulating peptide studied for supporting and balancing immune function.
Thymosin Alpha-1 is a peptide derived from the thymus gland, central to immune regulation. It’s studied for its role in modulating and supporting immune responses.
Prescription required. Final clinical decisions rest with the prescribing physician.
What is Thymosin Alpha-1?
Thymosin Alpha-1 is a naturally occurring peptide produced by the thymus, a key organ of the immune system. It’s researched for its ability to modulate immune function — supporting under-active responses and helping balance over-active ones — and has been studied internationally in several clinical contexts.
It is accessed through licensed compounding pharmacies under a physician’s prescription; it is not an FDA-approved finished product in the U.S., and FDA guidance on peptide compounding continues to evolve.
Potential benefits
Immune modulation
Studied for supporting and balancing immune responses.
Resilience support
Used in protocols aimed at immune resilience and recovery.
Well-characterized peptide
One of the more clinically studied immune peptides internationally.
Often used seasonally
Some protocols run in cycles around higher-demand periods.
How it works
How it’s taken
A subcutaneous injection, typically a few times per week, on a schedule set by the prescribing physician.
Typical protocol
Run in cycles with periodic reassessment; the physician sets the dose and frequency.
How ordering works
Complete the intake
Share your goals, health history, and current medications — about 5 minutes.
Physician evaluation
An independent, board-certified physician reviews your intake and, if appropriate, prescribes Thymosin Alpha-1 with a dosing protocol.
Compounded & shipped
The prescription is filled by a licensed compounding pharmacy and shipped to your door with instructions.
What to know before Thymosin Alpha-1
Thymosin Alpha-1 is a bioactive compound. The physician you’re connected with will review the relevant risks and contraindications for your situation before prescribing.
- •Injection-site reactions are the most common side effect.
- •Generally well tolerated; long-term U.S. data is limited.
- •Disclose autoimmune conditions and current medications — immune-modulating therapy may not suit everyone.
- •Source matters: gray-market “research only” peptides skip physician oversight and quality testing. FirstCall connects you with a licensed physician and a compounding pharmacy that follows USP standards.
Thymosin Alpha-1 FAQ
What is Thymosin Alpha-1 used for?
It’s studied for modulating and supporting immune function. It’s prescribed off-label under physician supervision and is not FDA-approved in the U.S.
Is it FDA-approved?
Not in the U.S. as a finished drug product; it is prepared by licensed compounding pharmacies and prescribed off-label.
How is it taken?
A subcutaneous injection a few times per week; the physician sets your dose and schedule.
Who should avoid it?
Anyone with autoimmune conditions should discuss it carefully — the physician will determine suitability.
How much does it cost?
Thymosin Alpha-1 starts from $199/month. Final pricing is confirmed after your physician evaluation. The initial evaluation is free.
Ready to start Thymosin Alpha-1?
Complete a short medical intake — a supervising physician reviews it and, if appropriate, writes your prescription, and a licensed pharmacy ships to your door.
Pricing & regulatory note: The $199/mo price is an indicative starting point confirmed by the compounding pharmacy after physician evaluation. Thymosin Alpha-1 is not an FDA-approved finished drug product; it is prepared by licensed compounding pharmacies and prescribed off-label. FDA guidance on peptide compounding continues to evolve and availability can change. A prescription is required.